![biostatisticians-launch-cancer-immu-data-portal-for-predicting-response-to-immune-checkpoint-blockade-immunotherapy](https://utterbuzz.com/wp-content/uploads/2022/01/biostatisticians-launch-cancer-immu-data-portal-for-predicting-response-to-immune-checkpoint-blockade-immunotherapy-640x349.png)
A new data portal called Cancer-Immu established by a team of biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors. With data from 3,652 samples for 16 cancer types, Cancer-Immu is the largest immune checkpoint blockade-related data portal for exploring immunogenomic connections.